期刊文献+

辛伐他汀对高糖高脂诱导人骨髓间充质干细胞凋亡的影响 被引量:2

Effects of simvastatin on the apoptosis of human mesenchymal stem cells induced by high glucose and saturated fatty acids
下载PDF
导出
摘要 背景:研究表明,他汀类药物能够促进骨髓间充质干细胞的增殖与黏附能力,抑制高糖高脂培养下骨髓间充质干细胞的凋亡。目的:观察辛伐他汀对高糖高脂诱导条件下人骨髓间充质干细胞凋亡的影响。方法:将0.001,0.01,0.1,1.0μmol/L辛伐他汀分别与高糖高脂诱导条件下人骨髓间充质干细胞培养48h,以正常培养骨髓间充质干细胞及高糖高脂诱导条件下培养的骨髓间充质干细胞为对照。倒置显微镜下观察细胞形态,MTT法比较不同浓度辛伐他汀对高糖高脂环境下骨髓间充质干细胞存活率的影响,应用流式细胞术检测细胞凋亡,加入PI3K/Akt信号转导通路抑制剂LY294002后辛伐他汀对骨髓间充质干细胞凋亡的影响。结果与结论:与高糖高脂诱导组比较,辛伐他汀0.01,0.1,1.0μmol/L组骨髓间充质干细胞存活率均升高(P<0.01),其中辛伐他汀浓度在0.1μmol/L时骨髓间充质干细胞存活率升高最显著(P<0.01);同时流式细胞仪检测结果显示,辛伐他汀0.01,0.1,1.0μmol/L组细胞凋亡率下降(P<0.01),其中0.1μmol/L组凋亡率下降最显著(P<0.01)。0.1μmol/L辛伐他汀对骨髓间充质干细胞的影响可被LY294002阻断。说明辛伐他汀能抑制高糖高脂诱导条件下骨髓间充质干细胞的凋亡,其机制可能与PI3K/Akt信号途径有关。 BACKGROUND:Previous studies demonstrated that statins can promote the proliferation and adhesion of bone marrow mesenchymal stem cells(BMSCs) ,inhibit apoptosis of BMSCs cultured with high glucose and saturated fatty acids. OBJECTIVE:To investigate the effects of simvastatin on the apoptosis of human mesenchymal stem cells induced by high glucose and saturated fatty acids. METHODS:Different concentrations of simvastatin(0.001,0.01,0.1,1.0 μmol/L) was cultured with BMSCs in presence of high glucose and saturated fatty acids for 48 hours. BMSCs cultured with normal bone marrow mesenchymal stem cells induced by high glucose and saturated fatty acids were as controls. Cell morphology was observed under the inverted microscope. Effect of simvastatin on cell survival rate of BMSCs in high glucose and saturated fatty acids was measured by MTT assay. Cell apoptosis was detected by flow cytometry. LY294002(PI3K inhibitor) was used to study the underlying mechanism of simvastatin effect on BMSCs apoptosis. RESULTS AND CONCLUSION:Compared with induced by high glucose and saturated fatty acid group,the survival rate of BMSCs in different concentrations of simvastatin(0.001,0.01,0.1,1.0 μmol/L) group was increased(P 0.01) ,especially in simvastatin at concentration of 0.1μmol/L(P 0.01) . Meanwhile,flow cytometry showed apoptosis rate was decreased in simvastatin at concentration of 0.01,0.1,1.0 μmol/L group(P 0.01) ,especially in 0.1 μmol/L group(P 0.01) . The effect of simvastatin at concentration of 0.1μmol/L on BMSCs could be blocked. The results suggested that simvastatin can inhibit BMSCs apoptosis induced by high glucose and saturated fatty acids,and its mechanism may be related to PI3K/Akt pathway.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第23期4207-4210,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献23

  • 1Nauck MA. Glucagon-like peptide-1 in type 2 diabetes: the β cell and beyond. Diabetes Obes Metab.2008;10:2-13.
  • 2Banerjeea M,Kumar A,Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun.2005;328(1 ):318-325.
  • 3Azamoush K,Maurel A,Sebbah L,et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J Thorac Cardiovasc Surg.2005; 130(1 ): 173-179.
  • 4Stolzing A,Coleman N,Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res.2006 9(1):31-35.
  • 5林海泓,施海明,肖萍,朱军,罗心平.普伐他汀对人骨髓间充质干细胞增殖分化及分泌功能的影响[J].中国组织工程研究与临床康复,2008,12(34):6612-6616. 被引量:3
  • 6Liao JK.Statins:potent vascular anti-inflammatory agents. Int J Clin Pract Suppl.2004;(143): 41-48.
  • 7Colter DC,Class R,Digirolamo CM,et aI.Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000;97(7): 3213-3218.
  • 8Barry FP, Murphy JM.Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol.2004;36(4):568-584.
  • 9Ghannam S, Bouffi C, Djouad F, et al.lmmunosuppression by mesenchymal stem cells:mechanisms and clinical applications. Stem Cell Res Ther. 2010;1(1):2.
  • 10Li YM, Schilling T, Benisch P, et al. Effects of high glucose on mesenchymal stem cellproliferation and differentiation. Biochem Biophys Res Commun.2007;363 (1):209-215.

二级参考文献20

  • 1Liem AH, van Boven AJ, Veeger NJ,et al. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J 2002;23(24):1931-1937
  • 2Fonarow GC, Wright RS, Spencer FA, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005;96(5):611-616
  • 3Anker SD, Clark AL, Winkler R,et al. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients. Int J Cardiol 2006;112(2):234-242
  • 4Assmus B, Urbich C, Alexandra A,et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003;92(9):1049-1055
  • 5Rupp S, Badorff C, Koyanagi M,et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 2004;99 (1):61-68
  • 6Spyridopoulos I, Haendeler J, Urbich C, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110(19):3136-3142
  • 7Fukuda K.Progress in myocardial regeneration and cell transplantation. Circ J 2005;69(12):1431-1446
  • 8Ohnishi S, Nagaya N. Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. Am J Nephrol 2007;27(3): 301-307
  • 9Sato Y, Araki H, Kato J,et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106(2):756-763
  • 10Reyes M,Lund T,Lenvik T,et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98(9): 2615-2625

共引文献2

同被引文献69

  • 1Mundy G,Garrett R,Harris S, et al. Stimulation of bone formationin vitro and in rodents by statins [ J]. Science, 1999,286 ( 5446):1946-1949.
  • 2Geesink RGT,Hoefnagels NHM( Bulstra SK. Osteogenic activity ofOP-1 bone morphogenetic protein ( BMP-7) in a human fibulasdefect [J]. J Bone Joint Surg Br,1999,81(4) :710-718.
  • 3Jadhavand SB,Jain GK. Stains and osteoporosis: new role for olddrugs [ J]. J Pharm Pharmacol,2006,58( 1) :3-18.
  • 4Weivodaand MM, Hohl RJ. Effects of famesyl pyrophosphateaccumulation on calvarial osteoblast differentiation [ J ].Endocrinology,2011,152(8) :3113-3122.
  • 5Weivodaand MM, Hohl RJ. The effects of direct inhibition ofgeranylgeranyl pyrophosphate synthase on osteoblast differentiation[J]. J Cell Biochem, 2011,112(6) :1506-1513.
  • 6Ruan F,Zheng Q, Wang J. Mechanisms of bone anabolismregulated by statins [J]. Biosci Rep,2012,32(6) :511-519.
  • 7Ohnaka K,Shimoda S,Nawata H,et al. Pitavastain enhanced BMP-2and Osteocalcin expression by inhibition of Rho-associated kinasein human osteoblasts [ J]. Biochem Biophys Res Commun, 2001,287(2) :337-342.
  • 8Yamashita M, Otsuka F, Mukai T, et al. Simvastatin antagonizestumor necrosis factor-alpha inhibition of bone morphogeneticproteins-2-induced osteoblast differentiation by regulating Smadsignaling and Ras/Rho-mitogen-activated protein kinase pathway[J].J Endocrinol. 2008,196(3) :601-613.
  • 9Luisetto G,Camozzi V. Statins, fracture risk, and bone remodeling[J]. J Endocrinol Invest, 2009,32(4 Suppl) :32-37.
  • 10Takenaka M, Hirade K, Tanabe K, et al. Simvastatin stimulatesVEGF release via p44/p42 MAP kinase in vascular smooth musclecells [J]. Biochem Biophys Res Commun, 2003, 301 ( 1 ) : 198-203.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部